Globus Medical (GMED) Cash from Investing Activities (2011 - 2026)

Globus Medical (GMED) has 16 years of Cash from Investing Activities data on file, last reported at -$182.7 million in Q1 2026.

• Quarterly Cash from Investing Activities fell 239.04% year-over-year to -$182.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$669.1 million (down 34983.89% YoY) and the FY2025 annual result came in at -$355.0 million, down 101.65% from the prior year.
• Cash from Investing Activities declined to -$182.7 million in Q1 2026, from -$111.4 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $320.6 million in Q4 2023 to a low of -$299.1 million in Q2 2025.
• A 5-year average of -$30.7 million and a median of -$46.6 million in 2024 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities surged 19069.23% — and 2025, when it tumbled 2782.14%.
• Tracing GMED's Cash from Investing Activities over 5 years: stood at -$60.5 million in 2022, then surged by 630.08% to $320.6 million in 2023, then slumped by 132.48% to -$104.1 million in 2024, then retreated by 7.04% to -$111.4 million in 2025, then slumped by 63.91% to -$182.7 million in 2026.
• The last three Cash from Investing Activities figures came in at -$182.7 million (Q1 2026), -$111.4 million (Q4 2025), and -$75.8 million (Q3 2025), per Business Quant data.